Posted on November 27, 2009 by ginnybarbour
There were two interesting developments in the ongoing story of ghostwriting documents relating to Wyeth and Prempro. First on Friday 20th the St Petersburg Times of Florida reported that Wyeth was to release up to 300, 000 documents which are currently under court seal. Apparently these documents relate to the development, sales and marketing of [...]
Filed under: Ghostwriting | Tagged: Ghostwriting, pharmaceutical industry | Leave a Comment »
Posted on September 18, 2009 by Guest Blog
Guest blog by Kim Klausner, Tobacco Digital Library Manager, University of California, San Francisco, USA
We’re pleased to announce the addition to the Drug Industry Document Archive (DIDA) of the Wyeth ghostwriting documents unsealed by a Federal judge last month at the request of PLoS Medicine, represented by Public Justice, and the [...]
Filed under: Ghostwriting, Public | Tagged: Ghostwriting, pharmaceutical industry, reporting | Leave a Comment »
Posted on September 4, 2009 by Larry Peiperl
The Halloween guest list continues to grow.
As reported in the New York Times and highlighted by Jim Edwards in BNET Pharma, the FY 2004 marketing plan for Forest Labs’ antidepressant Lexapro included $100,000 for “Bylined Articles”:
Bylined articles will allow us to fold Lexapro messages into articles on depression, anxiety, and co-morbidity developed by (or ghostwritten [...]
Filed under: Ghostwriting | Tagged: Ghostwriting, pharmaceutical industry | Leave a Comment »
Posted on August 25, 2009 by jocalynclark
In what appears to be the first report by an investigative journalist who mined the ghostwriting archive created by PLoS Medicine last week, a Canadian HRT expert is named as a participant in Wyeth’s ghostwriting scheme.
Barbara Sherwin, a McGill University psychology professor widely considered an expert on hormones, was the sole author of a 2000 [...]
Filed under: Ghostwriting, Media, Public | Tagged: Canada, Ghostwriting, pharmaceutical industry | 1 Comment »
Posted on August 21, 2009 by ginnybarbour
The following editorial will be published in the September issue of PLoS Medicine but is being posted on this blog today to coincide with the availability on the PLoS Medicine site of the ghostwriting documents released after our intervention in the Prempro case, which we received last week. They are posted in the form in [...]
Filed under: Authors, Ghostwriting, Public | Tagged: Ghostwriting, pharmaceutical industry, research ethics | 9 Comments »
Posted on August 7, 2009 by Guest Blog
Guest blog by Adriane Fugh-Berman
Arrangements are underway for posting the ghostwriting documents disclosed through the intervention of PLoS Medicine and the New York Times. While you look forward to exploring the parallel universe of ghostwriters, guest authors, and ghost handlers, PLoS Medicine will release selected documents on this blog.
Our story to date: Wyeth-Ayerst (“the client”) [...]
Filed under: Authors, Ghostwriting, Public | Tagged: Ghostwriting, medical literature, pharmaceutical industry | 3 Comments »
Posted on August 6, 2009 by Andrew Hyde
As mentioned in our guest blog on the Wyeth ghostwriting case, alongside The New York Times article are the released documents relating to a “case study” of ghostwriting outlined in the article. The documents explain how Wyeth used the medical communications company Design Write to outline and draft an article describing the hormone drugs as [...]
Filed under: Authors, Ghostwriting, Media, Public | Tagged: Ghostwriting, medical literature, pharmaceutical industry | 3 Comments »
Posted on August 5, 2009 by Guest Blog
Guest blog by Adriane Fugh-Berman
PLoS Medicine and the New York Times victorious in court; Public will have access to ghostwriting documents
A duo of standard-setting publications has achieved a stunning success in the battle to end industry tampering of medical literature. Fifteen hundred documents that contain unprecedented detail on how articles highlighting specific marketing messages are [...]
Filed under: Authors, Ghostwriting, Media, Public | Tagged: Ghostwriting, medical literature, pharmaceutical industry | 12 Comments »
Posted on July 25, 2009 by ginnybarbour
Today an Arkansas federal judge granted public access today to evidence that Wyeth Pharmaceuticals “ghostwrote” medical articles regarding its hormone therapy drug Prempro. Along with the New York Times, PLoS Medicine, represented by the law firm Public Justice, had sought to intervene in a court case of women bringing an action in relation to Prempro [...]
Filed under: Authors, Ghostwriting, Public | Tagged: Ghostwriting, medical literature, pharmaceutical industry | 1 Comment »
Pubcasts of PLoS Medicine papers
